GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 42 weeks, 31kg, and dual agonist was the hard part — 24 comments in the full submission. View in context.
154
c/survodutide·submitted 21 days ago by u/yannick_petrov

[Results] 42 weeks, 31kg, and dual agonist was the hard part

Cautionbranch of 5 comments

Quick one. Canada here. MASH works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 15 weeks and cost roughly what I expected. The admin was worse than the cost.…

Read the full submission and all 24 comments →

This branch

5 comments, started 20 days ago
u/cato_batista27 points·20 days ago

Yeah, glucagon co-agonism is genuinely different.

replysharereportpermalink
u/yannick_petrovOP12 points·20 days ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/cato_batista17 points·19 days ago

phase 14 data is interesting, phase 14 will be different

replysharereportpermalink
u/throwaway_wl20269 points·19 days ago

not approved, descriptive posts only

replysharereportpermalink
u/cormac_danquah13 points·19 days ago

the safety profile is not just tirzepatide amplified

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.